(Q28245071)

English

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

scientific article (publication date: 15 October 2014)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer (English)

0 references

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

author name string

Lucas de Sousa Cavalcante

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

language of work or name

English

0 references

publication date

15 October 2014

0 references

published in

European Journal of Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

volume

741

1 reference

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

page(s)

8-16

1 reference

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

cites work

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1164368

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/api/v1/citations/10.1038/SJ.ONC.1207272

retrieved

30 December 2023

Identifiers

DOI

10.1016/J.EJPHAR.2014.07.041

2 references

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2565804

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

OpenCitations bibliographic resource ID

2565804

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2565804

stated in

Europe PubMed Central

PubMed ID

25084222

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25084222%20AND%20SRC:MED&resulttype=core&format=json

(Q28245071)

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)